Orum Therapeutics to Present Preclinical Data for ORM-5029, a Novel Antibody Neodegrader Conjugate, at the AACR Annual Meeting 2022
BOSTON & DAEJEON, South Korea--(BUSINESS WIRE)--#AACR22--Orum Therapeutics, a biotechnology company pioneering the development of tumor-directed…